Company: EHC
Filing Date: 2025-04-01
Form Type: DEF 14A
Source: 0000785161-25-000013
Chunk: 1

Company: Encompass Health Corp
Filing Date: 2025-04-01
Form: DEF 14A
Chunk 1
---
 electronic or physical mail.

We will consider the items of business described in the Proxy Statement accompanying this letter and respond to any questions you may have. The Proxy Statement contains important information about the matters to be voted on and the process for voting, along with information about Encompass Health, its management and its directors.

Every stockholder’s vote is important to us . Even if you plan to attend the annual meeting by logging into the virtual annual meeting website, please promptly vote by submitting your proxy by phone, by internet or by mail. The “Commonly Asked Questions” section of the Proxy Statement and the enclosed proxy card contain detailed instructions for submitting your proxy.

On behalf of the directors, management and employees of Encompass Health, thank you for your continued support of and ownership in our company.

Sincerely,

Greg D. Carmichael Chairman of the Board of Directors

### ENCOMPASS HEALTH CORPORATION

#### Notice of Annual Meeting of Stockholders
| TIME              
 PLACE             |     | 11:00 a.m., central time, on Thursday, May 1, 2025                                                                                                                                                                                                                                                                                                                                                                                            
 This year’s annual meeting will be conducted by live webcast. You may attend and participate in the meeting by visiting www.virtualshareholdermeeting.com/EHC2025 and entering the 16-digit control number included on your proxy card or Notice of Internet Availability of Proxy Materials. If you hold your shares through an intermediary, such as a bank or broker, and do not have a control number, please contact the bank or broker. |
|:------------------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| ITEMS OF BUSINESS |     | •To elect 10 directors to the board of directors to serve until our 2026 annual meeting of stockholders.                                                                                                                                                                                                                                                                                                                                      
 ØThe board of directors recommends a vote FOR each nominee.                                                                                                                                                                                                                                                                                                                                                                                   
 •To ratify the appointment by Encompass Health’s Audit Committee of PricewaterhouseCoopers LLP as Encompass Health’s independent registered public accounting firm.                                                                                                                                                                                                                                                                           
 ØThe board of directors recommends a vote FOR ratification.                                                                                                                                                                                                                                                                                                                                                                                   
 •To approve, on an advisory basis, the compensation of the named executive officers as disclosed in Encompass Health’s Definitive Proxy Statement for the 2025 annual meeting.                                                                                                                                                                                                                                                                
 ØThe board of directors recommends a vote FOR the approval of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                               
 •To approve the 2025 Omnibus Performance Incentive Plan.